Biologics

Biologics are vital in providing precision-targeted therapies, making them potentially more effective in treating autoimmune diseases, cancers, and genetic conditions.

By combining expertise in chemistry and biology, MRIGlobal supports the complexity of biopharmaceuticals at various stages of development from research to manufacturing. Our capabilities span a diverse range of therapeutic modalities, such as gene therapies and nucleic acids, proteins and peptides, monoclonal antibodies and antibody drug conjugates, and cell therapies.

MRIGlobal’s expertise in the development of biologics can serve a transformative role in global health, creating the potential for more precise, affordable, and accessible treatments for an array of diseases.

Read more about our expertise in developing cell-based potency assays for multi-antigen oligonucleotide therapeutics at “Development and Validation of a Six-Plex Quantitative PCR Potency Assay for an Anti-Breast Cancer DNA Plasmid Vaccine”  

 

Interested in hearing more about our Biologics expertise, including our support for development of gene therapies, immune modulators, cell therapies, and monoclonal antibodies? Listen to this episode of the Science Diction podcast from MRIGlobal!

WORK WITH US

MRIGlobal looks forward to contributing our expertise where it matters most.

Use our Project Quote Tool to learn more about how we can help with your next endeavor.

Project Quote Tool

See Our Certifications

See Our Facilities